Digital transformation, artificial intelligence and start-up technologies are some of the topics that will be discussed at the event in November.
After one year into the transition period, it is clear that manufacturers are not where they need to be in meeting the compliance deadline.
Think outside of the box and approach your QMS with passion and creativity.
How in touch are you with current MDR guidelines?
No longer just the domain of bitcoin pundits and tech cowboys, blockchain technology has very real implications for the healthcare ecosystem—if we’re willing to give it a go.
Innovations are helping companies to maintain compliance while driving operational gains across their supply chain.
Excessive focus on compliance can create hurdles in cultivating quality and innovation.
Manufacturers must re-evaluate existing regulatory and compliance strategies to meet the new requirements.
Throughout 2018, device and diagnostic manufacturers have opportunities to address challenging market trends and turn internal change into ways of increasing business and goodwill from providers who purchase their technology.
Human factor engineering must account for all groups within the Diffusion of Innovation curve. Medical devices must work for the Innovators, and more importantly account for the Majority Adopters and Laggards.